Status
Conditions
Treatments
About
This is a prospective, open large cohort study to explore biomarkers for detecting early carcinogenesis of IPMN.
Full description
This prospective study was designed to explore biomarkers for detecting early carcinogenesis of IPMN. This study intends to prospectively and continuously enroll IPMN patients, and regularly collect biological samples including blood, urine, feces and saliva. We aimed to detect biomarkers which can predict the carcinogenesis of IPMN by multi-omics. The primary endpoint is the predictive accuracy of biomarkers for IPMN malignant transformation. The probability of IPMN malignant transformation , rates of surgical resection and survival after surgery are secondary endpoints.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
5,000 participants in 1 patient group
Loading...
Central trial contact
Tingbo Liang, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal